|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 35/02 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3823664 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19749096.4 |
| Date of filing the European patent application | 2019-07-18 | |
| (97) | Date of publication of the European application | 2021-05-26 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-08 |
| (46) | Date of publication of the claims translation | 2025-02-25 |
| (86) | Number | PCT/US2019/042447 |
| Date | 2019-07-18 |
| (87) | Number | WO 2020/018820 |
| Date | 2020-01-23 |
| (30) | Number | Date | Country code |
| 201862700596 P | 2018-07-19 | US | |
| 201862750968 P | 2018-10-26 | US | |
| 201962793645 P | 2019-01-17 | US |
| (72) |
SMITH, Eric , US
OLSON, Kara , US
DELFINO, Frank , US
DILILLO, David , US
KIRSHNER, Jessica , US
SINESHCHEKOVA, Olga , US
ZHANG, Qian , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bispecifiniai anti-BCMA X anti-CD3 antikūnai ir jų panaudojimas |
| BISPECIFIC ANTI-BCMA X ANTI-CD3 ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 7 | 162.00 EUR |
| 2026-07-18 |